Literature DB >> 15207438

Trace elements and cognitive impairment: an elderly cohort study.

C Smorgon1, E Mari, A R Atti, E Dalla Nora, P F Zamboni, F Calzoni, A Passaro, R Fellin.   

Abstract

Dementia is one of the most pressing public health problems with social and economic implication. The form called cognitive impairment non-dementia (CIND)represents a subclinical phase of dementia. Different studies have shown a possible effect of micro- and macro-nutrients on cognitive function. Trace elements, being involved in metabolic processes and redox reactions in the central nervous system (CNS), could influence the cognitive functions. This study evaluated the presence of an eventual correlation between serum trace element concentrations and cognitive function in a group of subjects with CIND and manifest dementia (Alzheimer dementia = AD, and vascular dementia = VaD), and compared them with a control group. Thirty -five patients were enrolled in this study. Each patient underwent a clinical and biochemical examination. We also performed a neuropsychological and functional assessment (the Milan overall dementia assessment = MODA, activities of daily living = ADL, and instrumental activities of daily living = IADL), and a computerized tomographic (CT) cerebral scan. Patients were than divided in 4 groups according to the obtained diagnosis (Controls, CIND, AD, VaD). The presence of any acute or chronic conditions, affecting cognitive functions, was considered as exclusion criteria. A blood sample was collected to determine iron (Fe), zinc (Zn), manganese (Mn), selenium (Se), cobalt (Co), chromium (Cr), copper (Cu),molybdenum (Mo) and aluminium (Al) serum concentrations (chromatographic,spectrophotometric methods). In our cohort we found a positive correlation between cognitive function, expressed as the MODA score, and Se, Cr, Co and Fe serum levels,while a negative correlation was observed between MODA score, Cu and Al serum levels.Moreover, some statistically significant differences in Se, Cr, Co, Cu and Al concentrations were found among the groups. According to these results, we may suppose that Se, Cr and Co protect cognitive function, Cu influences the evolution of cognitive impairment, while Al contributes to the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207438     DOI: 10.1016/j.archger.2004.04.050

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr Suppl        ISSN: 0924-7947


  21 in total

1.  DNA Damage, Copper and Lead Associates with Cognitive Function among Older Adults.

Authors:  A Meramat; N F Rajab; S Shahar; R A Sharif
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Alzheimer's Disease Association with Metals and Metalloids Concentration in Blood and Urine.

Authors:  Loreta Strumylaite; Rima Kregzdyte; Odeta Kucikiene; Dale Baranauskiene; Vaida Simakauskiene; Rima Naginiene; Gyte Damuleviciene; Vita Lesauskaite; Reda Zemaitiene
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

3.  Diphenyl diselenide-supplemented diet and swimming exercise enhance novel object recognition memory in old rats.

Authors:  José L Cechella; Marlon R Leite; Alisson R Rosario; Tuane B Sampaio; Gilson Zeni
Journal:  Age (Dordr)       Date:  2014-07-04

4.  Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.

Authors:  Rosanna Squitti; Carlo C Quattrocchi; Carlo Salustri; Paolo M Rossini
Journal:  Prion       Date:  2008-01-14       Impact factor: 3.931

5.  Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.

Authors:  Serena Bucossi; Stefania Mariani; Mariacarla Ventriglia; Renato Polimanti; Massimo Gennarelli; Cristian Bonvicini; Patrizio Pasqualetti; Federica Scrascia; Simone Migliore; Fabrizio Vernieri; Paolo M Rossini; Rosanna Squitti
Journal:  Int J Alzheimers Dis       Date:  2011-06-15

Review 6.  Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

7.  Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.

Authors:  Anne Ws Rutjes; David A Denton; Marcello Di Nisio; Lee-Yee Chong; Rajesh P Abraham; Aalya S Al-Assaf; John L Anderson; Muzaffar A Malik; Robin Wm Vernooij; Gabriel Martínez; Naji Tabet; Jenny McCleery
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

8.  Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.

Authors:  Rosanna Squitti; Carlo C Quattrocchi; Gloria Dal Forno; Piero Antuono; David R Wekstein; Concetta R Capo; Carlo Salustri; Paolo M Rossini
Journal:  Biomark Insights       Date:  2007-02-07

Review 9.  Importance and management of micronutrient deficiencies in patients with Alzheimer's disease.

Authors:  Bárbara Rita Cardoso; Cristiane Cominetti; Silvia Maria Franciscato Cozzolino
Journal:  Clin Interv Aging       Date:  2013-05-10       Impact factor: 4.458

10.  Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.

Authors:  Jenny McCleery; Rajesh P Abraham; David A Denton; Anne Ws Rutjes; Lee-Yee Chong; Aalya S Al-Assaf; Daniel J Griffith; Shireen Rafeeq; Hakan Yaman; Muzaffar A Malik; Marcello Di Nisio; Gabriel Martínez; Robin Wm Vernooij; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.